OM
NASDAQ HealthcareOutset Medical, Inc. - Common Stock
Medical Devices
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
๐ Market Data
| Price | $5.07 |
|---|---|
| Volume | 209,665 |
| Market Cap | 93.98M |
| Beta | 1.910 |
| RSI (14-Day) | 77.3 Overbought |
| 200-Day MA | $7.16 |
| 50-Day MA | $4.20 |
| 52-Week High | $21.98 |
| 52-Week Low | $3.00 |
| Forward P/E | -2.33 |
| Price / Book | 0.73 |
๐ฏ Investment Strategy Scores
OM scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (93/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ Institutional Whale (2/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find OM in your text
Paste any article, transcript, or post โ the tool will extract OM and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-06-02.